ProKidney Corp. Proceeds from Contributed Capital
ProKidney Corp. (PROK) reported Proceeds from Contributed Capital of $6.05 million for the 12-month period ending 2022-12-31, per its 10-K filed 2025-03-17.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromContributedCapital · last filed 2025-03-17
- ProKidney Corp. proceeds from contributed capital for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- ProKidney Corp. proceeds from contributed capital for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- ProKidney Corp. proceeds from contributed capital for the quarter ending 2022-06-30 was $500.00K.
- ProKidney Corp. proceeds from contributed capital for the quarter ending 2022-03-31 was $5.55M.
- ProKidney Corp. proceeds from contributed capital for fiscal 2022 was $6.05M, a 91.54% decline from fiscal 2021.
- ProKidney Corp. proceeds from contributed capital for fiscal 2021 was $71.50M, a 257.50% increase from fiscal 2020.
- ProKidney Corp. proceeds from contributed capital for fiscal 2020 was $20.00M.
| Period end | Proceeds from Contributed Capital 3 month | Proceeds from Contributed Capital 6 month | Proceeds from Contributed Capital 9 month | Proceeds from Contributed Capital 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $0.00 derived: sum of 2 quarters · filed 2025-03-17 | $500.00K derived: sum of 3 quarters · filed 2025-03-17 | $6.05M 10-K · filed 2025-03-17 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $500.00K derived: sum of 2 quarters · filed 2023-11-14 | $6.05M 10-Q · filed 2023-11-14 | $36.05M derived: sum of 4 quarters · filed 2024-03-22 |
| 2022-06-30 | $500.00K 10-Q · filed 2023-08-10 | $6.05M 10-Q · filed 2023-08-10 | $36.05M derived: sum of 3 quarters · filed 2024-03-22 | $47.55M derived: sum of 4 quarters · filed 2024-03-22 |
| 2022-03-31 | $5.55M 10-Q · filed 2023-05-11 | $35.55M derived: sum of 2 quarters · filed 2024-03-22 | $47.05M derived: sum of 3 quarters · filed 2024-03-22 | |
| 2021-12-31 | $30.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $41.50M derived: sum of 2 quarters · filed 2024-03-22 | $71.50M 10-K · filed 2024-03-22 | |
| 2021-09-30 | $11.50M 10-Q · filed 2022-11-14 | $41.50M 10-Q · filed 2022-11-14 | ||
| 2020-12-31 | $20.00M 10-K · filed 2023-03-28 |